This finding was further validated in our clinical cohort of 53 primary HCC cases, where tumor tissues showed significantly increased RBP7 mRNA expression compared to matched normal tissues (P < 0.05, Figure 1F), with 62.3% (33/53) of cases demonstrating tumor-specific RBP7 upregulation (Figure 1G). This evidence concerns the gene RBP7 and neoplasm.